Neuromodulation with Attention Bias Modification Training for Binge Eating Disorder (TANDEM)

King's College London

Status

Completed

Conditions

Binge-Eating Disorder

Treatments

Other: Simultaneous Attention Bias Modification Training and Transcranial Direct Current Stimulation (tDCS)

Study type

Interventional

Funder types

Other

Identifiers

NCT04424745

TANDEM01

Details and patient eligibility

About

Binge eating disorder (BED) is a common and disabling eating disorder (ED) which has significant effects on psychological wellbeing, physical health, and quality of life. Talking therapies, most notably cognitive behaviour therapy (CBT), are presently recommended for the treatment of BED. However, outcomes from treatment are inadequate. Therefore, there is a need for development of new treatments.

This study aims to investigate the feasibility of combining Attention Bias Modification Training (ABMT) and Transcranial Direct Current Stimulation (tDCS) to reduce binge-eating behaviour and craving for food in people with BED.

ABMT is a computerised training that seeks to alter responses towards food that people are not consciously aware of. During ABMT, participants are trained to 'look towards' low-calorie food and 'look away' from high-calorie food. TDCS is a safe, well tolerated, non-invasive form of brain stimulation which is suitable for supervised self-administration. It stimulates specific brain areas using a mild electrical current (2 mA) via small electrodes placed on the scalp. In this study, participants will be randomly allocated to receive either ABMT with real tDCS or ABMT with sham tDCS. ABMT and real/sham tDCS will be delivered simultaneously, i.e. participants will engage in ABM training whilst receiving tDCS. All participants will be remotely supervised by the study researcher for the duration of each treatment session.

Biological male and female adults (aged 18-60) of any gender will be eligible to take part if they have a DSM-V of BED and they are overweight or obese.

Taking part will involve completing 10 sessions of combined ABMT and real or sham tDCS over 2-3 weeks. Binge frequency, food craving and other outcomes will be measured at the start of the study, end of the study, and at the 6-week follow-up.

Enrollment

84 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Overweight or obese according to WHO criteria (BMI>25 kg/m²)
Meet criteria for full-syndrome DSM-5 Binge Eating Disorder (BED)
Right-handed
Must use and understand English as a language for everyday conversation
Access to a laptop or desktop computer with webcam

Exclusion criteria

Visual impairments that cannot be corrected with contact lenses or glasses
Pregnancy
History of neurological disease and/or seizure
Having any metallic implants anywhere in the head or body
History of head or eye injury
Significant health problems in the previous six months
Lifetime diagnosis of substance dependence, psychosis, bipolar disorder, borderline personality disorder
Other primary psychiatric disorder requiring treatment in its own right
Taking psychotropic medication other than a stable dosage of selective serotonin reuptake inhibitors (SSRI) for at least 14 days prior to study enrollment
Adults consuming more than 14 units of alcohol per week who are unwilling to reduce their alcohol intake for the duration of the treatment.
Current illicit drug use.
Learning difficulties that would preclude safe tDCS self-administration and/or completion of questionnaire measures and neurocognitive tasks.